GC Rieber VivoMega is announcing the launch of its premium VivoMega EPA+DHA Algae 2050 TGP Oils for the North American market at the Natural Products Expo West show in Anaheim, California.
Its high-concentration vegan omega-3 from microalgae offers purity with environmental and sustainable initiatives at the forefront.
“Adding EPA+DHA combination to our algae portfolio is a big win for us and our partners,” said Ståle Søfting, Sales and Marketing Director. “These EPA and DHA offerings provide a non-GMO, solvent-free, sustainable and alternative source for these essential fatty acids.”
Additionally, as the supply and increased costs of fish oil remain top of mind for suppliers and manufacturers, algae concentrates offer a great alternative to support the demands of consumers wanting omega-3s.”
Many algae products in the market are refined or concentrates only available in EE form.
VivoMega’s algae concentrate is 90% triglycerides (TG), which offers increased bioavailability for improved absorption in the body. It also comprises 73% long-chained omega-3 fatty acids and is Vegan certified.
Its SuperLight proprietary processing technology is designed and developed exclusively for algae oils. Its process utilises high-end technologies, allowing for gentle and non-invasive processing with superior oxidation protection.
This results in a product with exceptional quality parameters and optimal resource utilisation with little to zero waste.
The EPA+DHA algae is initially being launched in the US market, the world’s largest omega-3 ingredient market, with other markets to follow.
GC Rieber VivoMega’s products are also SEDEX-certified and fully aligned with the EU Green Deal initiatives and the UN Global Compact guidelines.
